HYDROCHLOROTHIAZIDE; IRBESARTAN (HYDROCHLOROTHIAZIDE; IRBESARTAN) — FDA Approval ANDA201616 (CIPLA LIMITED)
HYDROCHLOROTHIAZIDE; IRBESARTAN (HYDROCHLOROTHIAZIDE; IRBESARTAN) — FDA Approval ANDA201616 (CIPLA LIMITED) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: HYDROCHLOROTHIAZIDE; IRBESARTAN; Active ingredients: HYDROCHLOROTHIAZIDE; IRBESARTAN; Application number: ANDA201616.
| Brand name | HYDROCHLOROTHIAZIDE; IRBESARTAN |
|---|---|
| Active ingredients | HYDROCHLOROTHIAZIDE; IRBESARTAN |
| Application number | ANDA201616 |
| Sponsor | CIPLA LIMITED |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | None (Tentative Approval) |
| Products in application | 2 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →